Category: Business of health

9 12/16/2015

Opdivo ads vs. the reality of stage IV cancer treatment

4 12/9/2015

Is it ok for journalists to attend Bayer-funded training on new cancer treatments?

2 12/8/2015

Flying under journalists’ radars: brain-enhancing supplements dubbed ‘nootropics’

11/3/2015

The hospital-media partnership: promoting public health or inducing public demand?

10/28/2015

Trans-Pacific trade pact’s pharma provisions lack media scrutiny

10 10/27/2015

Why the media must play a bigger role in policing unsafe medical devices

2 10/20/2015

How fast to “cures” and at what cost? Politico forum tilts toward pharma-friendly messaging

2 10/14/2015

Sponsored content, new cholesterol drugs, and the political process

1 10/8/2015

Was Turing Pharmaceuticals’ 5000% price increase a tipping point?

2 9/18/2015

Another potentially troubling “partnership” between a news org & Mayo Clinic